391 related articles for article (PubMed ID: 23503527)
21. Toll-Like Receptor Signaling and Its Inducible Proteins.
Satoh T; Akira S
Microbiol Spectr; 2016 Dec; 4(6):. PubMed ID: 28084212
[TBL] [Abstract][Full Text] [Related]
22. Role of toll-like receptors in immune responses to chlamydial infections.
Joyee AG; Yang X
Curr Pharm Des; 2008; 14(6):593-600. PubMed ID: 18336303
[TBL] [Abstract][Full Text] [Related]
23. The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis.
Sun L; Liu W; Zhang LJ
J Immunol Res; 2019; 2019():1824624. PubMed ID: 31815151
[TBL] [Abstract][Full Text] [Related]
24. Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword.
Dajon M; Iribarren K; Cremer I
Immunobiology; 2017 Jan; 222(1):89-100. PubMed ID: 27349597
[TBL] [Abstract][Full Text] [Related]
25. [Toll-like receptors in development and function of the hematopoietic system].
Vadillo E; Pelayo R
Rev Invest Clin; 2012; 64(5):461-76. PubMed ID: 23544309
[TBL] [Abstract][Full Text] [Related]
26. Pathogen recognition and Toll-like receptor targeted therapeutics in innate immune cells.
Tartey S; Takeuchi O
Int Rev Immunol; 2017 Mar; 36(2):57-73. PubMed ID: 28060562
[TBL] [Abstract][Full Text] [Related]
27. Toll-like receptors as therapeutic targets in cystic fibrosis.
Greene CM; Branagan P; McElvaney NG
Expert Opin Ther Targets; 2008 Dec; 12(12):1481-95. PubMed ID: 19007318
[TBL] [Abstract][Full Text] [Related]
28. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
29. Toll-like receptors: Triggers of regulated cell death and promising targets for cancer therapy.
Yang Y; Feng R; Wang YZ; Sun HW; Zou QM; Li HB
Immunol Lett; 2020 Jul; 223():1-9. PubMed ID: 32311408
[TBL] [Abstract][Full Text] [Related]
30. Toll-Like Receptors: General Molecular and Structural Biology.
Behzadi P; García-Perdomo HA; Karpiński TM
J Immunol Res; 2021; 2021():9914854. PubMed ID: 34195298
[TBL] [Abstract][Full Text] [Related]
31. Regulation of toll-like receptor (TLR) signaling pathways in atherosclerosis: from mechanisms to targeted therapeutics.
Jin M; Fang J; Wang JJ; Shao X; Xu SW; Liu PQ; Ye WC; Liu ZP
Acta Pharmacol Sin; 2023 Dec; 44(12):2358-2375. PubMed ID: 37550526
[TBL] [Abstract][Full Text] [Related]
32. Toll-like receptors in breast cancer immunity and immunotherapy.
Zhou J; Zhang L; Liu S; DeRubeis D; Zhang D
Front Immunol; 2024; 15():1418025. PubMed ID: 38903515
[TBL] [Abstract][Full Text] [Related]
33. Important aspects of Toll-like receptors, ligands and their signaling pathways.
Chang ZL
Inflamm Res; 2010 Oct; 59(10):791-808. PubMed ID: 20593217
[TBL] [Abstract][Full Text] [Related]
34. Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity.
Duan T; Du Y; Xing C; Wang HY; Wang RF
Front Immunol; 2022; 13():812774. PubMed ID: 35309296
[TBL] [Abstract][Full Text] [Related]
35. Toll-like receptors.
Takeda K; Akira S
Curr Protoc Immunol; 2015 Apr; 109():14.12.1-14.12.10. PubMed ID: 25845562
[TBL] [Abstract][Full Text] [Related]
36. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity.
Krieg AM; Vollmer J
Immunol Rev; 2007 Dec; 220():251-69. PubMed ID: 17979852
[TBL] [Abstract][Full Text] [Related]
37. Toll-Like Receptors, Infections, and Rheumatoid Arthritis.
Arleevskaya MI; Larionova RV; Brooks WH; Bettacchioli E; Renaudineau Y
Clin Rev Allergy Immunol; 2020 Apr; 58(2):172-181. PubMed ID: 31144208
[TBL] [Abstract][Full Text] [Related]
38. The subversion of toll-like receptor signaling by bacterial and viral proteases during the development of infectious diseases.
Ciaston I; Dobosz E; Potempa J; Koziel J
Mol Aspects Med; 2022 Dec; 88():101143. PubMed ID: 36152458
[TBL] [Abstract][Full Text] [Related]
39. Negative regulatory approaches to the attenuation of Toll-like receptor signaling.
Anwar MA; Basith S; Choi S
Exp Mol Med; 2013 Feb; 45(2):e11. PubMed ID: 23429360
[TBL] [Abstract][Full Text] [Related]
40. The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases.
Lin Q; Li M; Fang D; Fang J; Su SB
Int Immunopharmacol; 2011 Oct; 11(10):1422-32. PubMed ID: 21600309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
